Understanding Myeloma News About Secondary Cancers and Clotting

May 28, 2012

Press Releases

Dr. James Berenson helps patients understand new FDA recommendations regarding the use of lenalidomide (Revlimid) and a study from Sweden regarding increased risk of blot clots for myeloma patients. Dr. Berenson also previews the topics that he believes will be important for patients at the upcoming ASCO conference.

, ,

Comments are closed.

Scroll Up